{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:35:48Z","timestamp":1762508148815,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s40261-020-00924-4","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T10:05:46Z","timestamp":1591610746000},"page":"687-693","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Problem with Amphotericin"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7627-6893","authenticated-orcid":false,"given":"Gillian","family":"Cavell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"924_CR1","unstructured":"Drug Safety Update. Volume 11, Issue 12. 2018. https:\/\/www.gov.uk\/drug-safety-update\/parenteral-amphotericin-b-reminder-of-risk-of-potentially-fatal-adverse-reaction-if-formulations-confused."},{"key":"924_CR2","unstructured":"National Patient Safety Agency. Rapid Response Report. Risk of confusion between lipid and non-lipid formulations of injectable amphotericin. 2007. https:\/\/www.sps.nhs.uk\/articles\/npsa-alert-non-lipid-and-lipid-formulations-of-injectable-amphotericin-2007\/."},{"key":"924_CR3","unstructured":"Institute for Safe Medication Practices (ISMP) Medication error prevention \u201cToolbox\u201d. 1999. https:\/\/www.ismp.org\/resources\/medication-error-prevention-toolbox."},{"key":"924_CR4","unstructured":"British National Formulary 76. Amphotericin. https:\/\/bnf.nice.org.uk.. Accessed 28th Oct 2019."},{"issue":"3","key":"924_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1592\/phco.25.3.426.61603","volume":"25","author":"J Mohr","year":"2005","unstructured":"Mohr J, Hall A, Ericsson C, Ostrosky-Zeichner L. Fatal amphotericin B overdose due to administration of nonlipid formulation instead of lipid formulation. Pharmacotherapy. 2005;25(3):426\u20138.","journal-title":"Pharmacotherapy"},{"key":"924_CR6","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1345\/aph.1H157","volume":"40","author":"D Burke","year":"2006","unstructured":"Burke D, Lal R, Finkel K, Samuels J, Foringer J. Acute amphotericin B overdose. Ann Pharmacother. 2006;40:2254\u20139. https:\/\/doi.org\/10.1345\/aph.1H157.","journal-title":"Ann Pharmacother"},{"key":"924_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/13693780701658280","volume":"46","author":"S Groeneveld","year":"2008","unstructured":"Groeneveld S, Verweij P, Van\u2019t Hek L, Bokkerink J, Warris A. Amphotericin B deoxycholate overdose due to administration error in paediatric patients. Med Mycol. 2008;46:185\u20137. https:\/\/doi.org\/10.1080\/13693780701658280.","journal-title":"Med Mycol"},{"key":"924_CR8","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1345\/aph.1R527","volume":"47","author":"G Wang","year":"2013","unstructured":"Wang G, Banerji S, Roussil T, Heard K. Survival after amphotericin B overdose treated with plasmapheresis. Ann Pharmacother. 2013;47:e9. https:\/\/doi.org\/10.1345\/aph.1R527.","journal-title":"Ann Pharmacother"},{"key":"924_CR9","doi-asserted-by":"publisher","first-page":"c6467","DOI":"10.1136\/bmj.c6467","volume":"341","author":"C Dyer","year":"2010","unstructured":"Dyer C. Hospital pays out six figure sum to widow for error over antifungal drug. BMJ. 2010;341:c6467. https:\/\/doi.org\/10.1136\/bmj.c6467.","journal-title":"BMJ"},{"key":"924_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s40800-016-0028-6","volume":"3","author":"M Fleury","year":"2016","unstructured":"Fleury M, Fonzo-Christe C, Normand C, Bonnabry P. Confusion between two amphotericin B formulations leading to a paediatric rehospitalisation. Drug Saf Case Rep. 2016;3:4. https:\/\/doi.org\/10.1007\/s40800-016-0028-6.","journal-title":"Drug Saf Case Rep"},{"key":"924_CR11","unstructured":"UKMi. In use product safety assessment report for methylprednisolone and medroxyprogesterone. 2014. https:\/\/www.sps.nhs.uk\/wp-content\/uploads\/2016\/03\/methylprednisolone_medroxyprogesteroneJun2014.pdf. Accessed 14 Jan 2020."},{"key":"924_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1046\/j.1525-1497.2002.11056.x","volume":"17","author":"T Lesar","year":"2002","unstructured":"Lesar T. Prescribing errors involving medication dosage forms. J Gen Intern Med. 2002;17:579\u201387.","journal-title":"J Gen Intern Med"},{"key":"924_CR13","unstructured":"Pharmacy Department. King\u2019s College Hospital. Sure-MED Alert; 1994 (unpublished)."},{"key":"924_CR14","unstructured":"National Injectable Medicines Guide-Medusa. https:\/\/medusa.wales.nhs.uk\/IVGuideDisplay.asp. Accessed 14 Jan 2020."},{"key":"924_CR15","unstructured":"Gilead Sciences Ltd. Summary of product characteristics. AmBisome liposomal 50mg powder for dispersion for infusion. 2019. https:\/\/www.medicines.org.uk\/emc\/product\/1022\/smpc. Accessed 14 Jan 2020."},{"issue":"1","key":"924_CR16","first-page":"24","volume":"22","author":"C Koczmara","year":"2011","unstructured":"Koczmara C, Richardson H, Hyland S, Lee CSY, Hillebrand N. ALERT: Mix-ups between conventional and lipid formulations of amphotericin can be extremely dangerous. Dynamics. 2011;22(1):24\u20136.","journal-title":"Dynamics"},{"key":"924_CR17","unstructured":"Institute of Safe Medication Practices Canada. Ontario critical incident learning. Errors continue with Amphotericin B. 2015. Issue 14. https:\/\/www.ismp-canada.org\/download\/ocil\/ISMPCONCIL2015-14_AmphotericinB.pdf."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-020-00924-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-020-00924-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-020-00924-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T23:50:36Z","timestamp":1623109836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-020-00924-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1007\/s40261-020-00924-4","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"type":"print","value":"1173-2563"},{"type":"electronic","value":"1179-1918"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"8 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}